A critical advance in cancer investigation is emerging with the use of VHH fragments to re-engage damaged p53. This essential malignant inhibitor protein is frequently lost in various forms of cancer, resulting https://7bookmarks.com/story21803585/vhh-fragments-reactivate-tumor-suppressor-p53-new-new-hope-for-malignant-management